Atovaquone Suspension
Product Images NDC 73190-098

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 73190-098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (098 21 Bottle)

Label for AvKARE ATOVAQUONE Oral Suspension, USP, 750 mg/5 mL strength. The oral suspension is prescription-only with a net content of 210 mL. Label includes dosage information per 5 mL teaspoonful, storage instructions, and manufacturing details from AvKARE in Pulaski, TN.*

FDA Label Image

Structure (Atovaquone Oral Suspension 1)

Chemical structure of atovaquone, showing its molecular framework including aromatic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.